505(b)(2) means A new drug application that contains full reports of investigations of safety and effectiveness but where at least some of the information required for approval comes from studies not conducted by or for the applicant and for which the applicant has not obtained a right of reference. in FDA




Similar to 505(b)(2)

ACTIS - Aids Clinical Trials Information Service
ACUS - Administrative Conference of the United States
ACWA - Administrative Careers With America
AD - Action Due
ad lib - as much as needed
ADA - American Dental Association
ADA - Americans with Disabilities Act of 1990

View all in FDA